|Systematic (IUPAC) name|
|(what is this?)|
Afloqualone (Arofuto) is a quinazolinone-class GABAergicdrug and is an analogue of methaqualone developed in the 1970s by a team at Tanabe Seiyaku. It has sedative and muscle-relaxant effects resulting from its agonist activity at the β subtype of the GABAa receptor , and has had some clinical use, although it causes photosensitization as a side-effect that can cause skin problems such as dermatitis.
- US Patent 3966731 - 2-Fluoromethyl-3-o-tolyl-6-amino-4(3H)-quinazolinone
- Ochiai T, Ishida R. Pharmacological studies on 6-amino- 2-fluoromethyl- 3-(O-tolyl)- 4(3H)- quinazolinone (afloqualone), a new centrally acting muscle relaxant. (II) Effects on the spinal reflex potential and the rigidity. Japanese Journal of Pharmacology. 1982 Jun;32(3):427-38.
- Ishikawa T, Kamide R, Niimura M. Photoleukomelanodermatitis (Kobori) induced by afloqualone. Journal of Dermatology. 1994 Jun;21(6):430-3.
|This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it.|
|This sedative-related article is a stub. You can help Wikipedia by expanding it.|